CD274 and melanoma: Regarding immune therapy resistance, whereas PD-L1 expression has been demonstrated to be a poor prognostic factor for malignant melanoma [106], Vu et al. [14] found PD-L1 to be upregulated when RAC1P29S was expressed, whereas it was downregulated when RAC1P29S was depleted.